Trevena to Present at the JMP Securities Life Sciences Conference

Trevena

CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, Inc. will participate in a fireside chat at the JMP Securities Life Sciences Conference being held virtually June 16 – 17, 2021.

Presentation Details

Date: Wednesday, June 16, 2021
Time: 1:30 pm Eastern Time
Presenter: Carrie Bourdow, President & CEO
Webcast: https://wsw.com/webcast/jmp49/trvn/1718600

A link to the webcast will be available on the Events page of the Investors section of the Company’s website at https://www.trevena.com/investors/events-presentations/ir-calendar. A replay of the presentation will be archived on the website and available for approximately 30 days following the event. Please contact your JMP Securities representative to schedule virtual one-on-one meetings with Trevena during the conference.

READ:  Aclaris Announces Pricing of Public Offering of Common Stock

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments